FundRx
VC Fund
New York, United States
FundRx is a healthcare venture capital firm and platform.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries FundRx invests in
Stages FundRx invests in
Countries FundRx invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Emmanuel Fombu
|
|||
Javier Gonzalez-Zabaleta
|
|||
Khan Siddiqui
|
|||
Ruchi Dana
|
|||
| See all 10 contacts → | |||
Investment Focus
Industry
- Health Care 7 (78%)
- Medical 2 (22%)
- Biotechnology 2 (22%)
- Medical Device 2 (22%)
- Information Technology 2 (22%)
Stage
- Series A 6 (67%)
- Seed 3 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dr Eddie Guzdar
Speaker and Venture Capital - Digital Technologies / Artificial Intelligence / Blockchain
|
Speaker and Venture Capital - Digital Technologies / Artificial Intelligence / Blockchain | Total investments: 0 | Find email | |
|
Emmanuel Fombu
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
|
Javier Gonzalez-Zabaleta
Venture Fellow
|
Venture Fellow | Total investments: 0 | Find email | |
|
Khan Siddiqui
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
|
Ruchi Dana
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lucy Goods
|
Lucy Goods operates as a nicotine alternative company. Lucy’s mission is to reduce tobacco-related harm to zero. They provide next-generation nicotine products, with just pure nicotine and food-grade ingredients. The company provides a cleaner convenient alternative to the products on the market. | $10M / Series A / Feb 24, 2020 | |
CloudCath
|
CloudCath is offering a sensor enabled digital platform for peritoneal dialysis patients that provides early complication detection and safely reduces the number of monthly patient visits. | $12M / Series A / Feb 13, 2020 | |
ixlayer
|
ixlayer is an industry leader in the health-tech ecosystem, providing innovative solutions for enabling health systems, payors, biopharma, and health-focused companies to offer health testing in a virtual environment. The ixlayer platform delivers end-to-end solutions for the technical, security, regulatory, and user experience components ofcomplex health testing. As the industry shifts to remote and virtual care options, ixlayer is powering patient engagement and preventative health strategies through virtual health testing, at scale. The ixlayer solution can be added to existing patient engagement platforms and patient portals to enable real time health and wellness lab testing. Founded in 2018, ixlayer currently supports millions of patients and has launched hundreds of testing programs for large organizations, health systems and every level of the government. | Seed / Jul 01, 2019 | |
Osmosis
|
Osmosis is a personalized learning platform that helps you retain more, gain a deeper understanding of concepts & feel more prepared for your courses & exams. Osmosis empowers the clinicians and caregivers with the best learning experience. | $4M / Series A / Jun 11, 2019 | |
Mightier
|
Mightier is a gaming platform and family program scientifically-proven to help kids regulate their emotions. It is a bioresponsive program that harnesses the mind-body connection to build emotional regulation in its players. Its program of bioresponsive video games, developed at Boston Children's Hospital and Harvard Medical School, aims tohelp children with behavioral and emotional challenges learn how to harness emotions in daily life.Mightier was founded in 2016 and is headquartered in Boston, Massachusetts. | $6.6M / Series A / May 21, 2019 | |
Contraline
|
Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible. | $3M / Seed / Sep 18, 2018 | |
Wellth
|
Our healthcare system assumes we make decisions based on what is best for us. But it’s not that simple. Everyday stressors often cloud our judgement as to what’s best in the long run. For people with chronic conditions, this can make healthy habit formation difficult. Wellth is a venture-backed digital health company that improves adherence inchronic disease populations. Using the science of behavioral economics—combined with an appreciation for human nature—we uncover and address the unique obstacles that prevent people with chronic conditions from improving patient outcomes. Our program goes beyond current efforts to boost adherence with technology, reminders, and coaching solutions using contingency management and loss aversion to create motivation, behavior change and improve population health at scale.In addition to our RCT-proven outcomes, our easy-to-use mobile platform experience has been proven by health plans, providers, and other organizations to empower members with the incentives and support system they need to establish new healthy habits. Key outcomes for members include improved med and care plan adherence, reduction in readmissions, hospitalizations, and ED utilization, improved PDC, and more. Learn more at www.wellthapp.com. | $5.1M / Seed / Sep 02, 2018 | |
Buoy Health
|
Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. Foremployers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts. | $6.7M / Series A / Aug 09, 2017 | |
Sonavex
|
Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling cliniciansto measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes. | $4.5M / Series A / Apr 24, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does FundRx invest in?
FundRx invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Seed stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact FundRx?
Public channels for FundRx include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at FundRx?
The team at FundRx includes Dr Eddie Guzdar (Speaker and Venture Capital - Digital Technologies / Artificial Intelligence / Blockchain), Emmanuel Fombu (Venture Partner) and Javier Gonzalez-Zabaleta (Venture Fellow), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
